BE641880A - - Google Patents

Info

Publication number
BE641880A
BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
Authority
BE
Belgium
Application number
BE641880A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641880A publication Critical patent/BE641880A/xx

Links

BE641880A 1962-12-27 1963-12-27 BE641880A (en:Method)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP6427663 1963-10-29
JP5741963 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
BE641880A true BE641880A (en:Method) 1964-04-16

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641880A BE641880A (en:Method) 1962-12-27 1963-12-27

Country Status (5)

Country Link
BE (1) BE641880A (en:Method)
FR (1) FR3150M (en:Method)
GB (1) GB1080599A (en:Method)
LU (1) LU45106A1 (en:Method)
NL (1) NL302572A (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
EP1824563B1 (en) 2004-11-26 2010-02-10 UCL Business PLC Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
CA3205755A1 (en) 2009-04-03 2010-10-07 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
MX2011013129A (es) 2009-06-08 2012-03-14 Ucl Business Plc Tratamiento de hipertension portal y restauracion de la funcion hepatica usando fenilacetato de l-ornitina.
AU2011312042B2 (en) 2010-10-06 2015-08-20 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
EP3223829B1 (en) 2014-11-24 2019-10-23 UCL Business Plc. Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
WO2017031131A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
KR20200024145A (ko) 2017-05-11 2020-03-06 오세라 테라퓨틱스, 아이엔씨. L-오르니틴 페닐아세테이트의 제조방법

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
NL302572A (en:Method)
FR3150M (fr) 1965-02-22
GB1080599A (en) 1967-08-23
LU45106A1 (en:Method) 1964-02-24

Similar Documents

Publication Publication Date Title
BE629198A (en:Method)
BE628220A (en:Method)
BE622730A (en:Method)
LU45106A1 (en:Method)
BE631700A (en:Method)
BE631659A (en:Method)
BE631152A (en:Method)
BE629571A (en:Method)
BE629479A (en:Method)
BE628342A (en:Method)
BE628207A (en:Method)
BE627684A (en:Method)
BE627212A (en:Method)
BE626995A (en:Method)
BE695686A (en:Method)
BE622359A (en:Method)
BE638455A (en:Method)
BE638436A (en:Method)
BE637434A (en:Method)
BE626517A (en:Method)
BE626513A (en:Method)
BE626478A (en:Method)
BE626382A (en:Method)
BE626376A (en:Method)
BE626328A (en:Method)